NYQUIL COLD & FLU OTC
Generic Name and Formulations:
Acetaminophen 325mg, doxylamine succinate 6.25mg, dextromethorphan HBr 15mg; per liquiCap.
Procter & Gamble Pharmaceuticals
Indications for NYQUIL COLD & FLU:
Cough, sore throat, rhinorrhea, fever, headache, minor aches and pains.
2 caps every 6hrs; max 4 doses/24hrs.
During or within 14 days of MAOIs. Concomitant other acetaminophen products.
Hepatic dysfunction. Glaucoma. GI or GU obstruction. Asthma. Lower respiratory disoders. Pregnancy. Nursing mothers.
Analgesic + antihistamine + antitussive.
See Contraindications. Hypertensive crisis with MAOIs. Increased risk of hepatotoxicity with ≥3 alcoholic drinks/day; avoid. Increased CNS effects with other CNS depressants.
Drowsiness, anticholinergic effects, excitability in children, hepatotoxicity (overdosage).
LiquiCaps—12, 20, 40, 60; Liq—6oz, 10oz
Endocrinology Advisor Articles
- Subclinical Hypothyroidism: Controversies in Testing and Treatment
- Favorable Outcomes With Second-Generation Insulin Analogs in Type 2 Diabetes
- Fatigue Management Contributes to Effective Endometriosis Care
- Assessment of Low-Dose Aspirin As Chemoprevention in Type 2 Diabetes
- Treatment With Alemtuzumab May Frequently Induce Thyroid Dysfunction
- Using Latent Class Trajectory Analysis to Determine Glucose Response Curve Patterns
- First CGM System With Implantable Glucose Sensor Approved
- Empagliflozin, Linagliptin Combination Therapy vs Linagliptin Monotherapy for Type 2 Diabetes
- Risk for Below Knee Amputations With Canagliflozin vs Other Antihyperglycemic Agents
- Two Phases of C-Peptide Decline Identified in Type I Diabetes
- Risk for Hypoglycemia During Titration With Insulin Glargine 100 U/mL in T2D
- Trulicity Labeling Updated to Include Data on T2D Patients With CKD
- New Data Support Long-Term Cardiovascular Safety of Linagliptin in T2D
- Peer-Led Education Helps Physicians Save Time With EHRs
- As Immigration Policies Tighten, Physician Shortage Concerns Grow